ThermoGenesis Holdings to Participate in Investor Conferences in September

Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a leader in cell processing technologies, announced participation in two upcoming investor conferences in September 2020. CEO Chris Xu will present at the LD Micro 500 on September 2 at 5:00 pm ET, with a live webcast available on their website. CFO Jeff Cauble will present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 15 at 12:00 pm ET, also accessible via webcast. Archived replays of both presentations will be available for 90 days post-conference.

RANCHO CORDOVA, Calif., Aug. 31, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced management's participation in the following investor conferences in September.

• September 1-4: LD Micro 500. Chris Xu, Ph.D., Chief Executive Officer of ThermoGenesis, will present a company overview at this virtual conference on Wednesday, September 2, at 5:00 pm ET. A live webcast of the presentation will be available on the ThermoGenesis website at: https://ThermoGenesis.com/investors/news-and-events/events-webcasts.
  An archived replay will be available for a period of 90 days after the conference.
• September 14-16: H.C. Wainwright 22^nd Annual Global Investment Conference. Jeff Cauble, Chief Financial Officer of ThermoGenesis, will present a company overview at this virtual conference on Tuesday, September 15, at 12:00 pm ET. A live webcast of the presentation will be available on the ThermoGenesis website at: https://ThermoGenesis.com/investors/news-and-events/events-webcasts.
  An archive replay will be available for a period of 90 days after the conference.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact: 
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact: 
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-participate-in-investor-conferences-in-september-301120615.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When is ThermoGenesis presenting at the LD Micro 500?

ThermoGenesis will present at the LD Micro 500 on September 2, 2020, at 5:00 pm ET.

Who from ThermoGenesis is speaking at the LD Micro 500?

CEO Chris Xu will present at the LD Micro 500 conference.

When can I watch the ThermoGenesis presentation from H.C. Wainwright?

You can watch the ThermoGenesis presentation from the H.C. Wainwright 22nd Annual Global Investment Conference on September 15, 2020, at 12:00 pm ET.

How can I access the webcasts of ThermoGenesis presentations?

Webcasts of the presentations can be accessed on the ThermoGenesis website, with archived replays available for 90 days.

What is the focus of ThermoGenesis Holdings?

ThermoGenesis develops automated technologies for CAR-T and other cell-based therapies.